11 December.
The announcement of a new 10,000 sq m bio-incubator for the Edinburgh BioQuarter confirms the latest £24 million (E26.4 million) investment in the Scottish life sciences cluster.
The facility will be jointly funded by the UK Department for Business Innovation and Skills through the Strategic Investment Fund and Scottish Enterprise. Welcoming the announcement, Lena Wilson, chief executive of Scottish Enterprise, said: "The BioQuarter is one of the largest projects of its type in Europe and this funding will allow the partners to cement Scotland's position as one of the most dynamic locations for life sciences globally."
The bio-incubator is targeted at start-up and spin-out biotechnology companies, and will help to create 200 jobs in Edinburgh over the next five years. It will offer access to high-cost specialized equipment, advice, mentoring and expertise to support successful product development.
Young & Partners Pharmaceutical Executive Summit 2024: Brave New World – Where Are We Heading?
October 23rd 2024Peter Marks, director, Center for Biologics Evaluation and Research, FDA, presented the keynote presentation on the future of gene therapy as part of the 20th Annual Young & Partners Pharmaceutical Executive Summit held at the Yale Club of New York.
The Transformative Role of Medical Information in Customer Engagement
October 3rd 2024Stacey Fung, Head of Global Medical Information at Gilead Lifesciences, delves into the evolving role of Medical Information (MI) in the pharmaceutical industry. Covering key topics like patient engagement through omnichannel strategies, combating misinformation, and leveraging AI to enhance medical inquiries, the conversation with Stacey highlights MI's critical role in ensuring patient safety and supporting drug development. She also shares her professional journey and tidbits for early career professionals on professional development.
Unlocking value and cost savings in patient services with technology and talent
October 2nd 2024Traci Miller, Director, Sonexus™ Access and Patient Support, Cardinal Health, discusses the current digital trends in the patient services industry and how the optimal balance of technology and talent can transform manufacturer-sponsored patient support programs. Hear how Cardinal Health combines best-in-class program and pharmacy operations with smart digital tools to ensure product and patient success and reduce operational costs.